Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 2
2014 7
2015 4
2016 7
2017 9
2018 10
2019 11
2020 14
2021 8
2022 6
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Results by year
Filters applied: . Clear all
Page 1
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, Glaessgen A, Carlsson S, Grönberg H, Nordström T; STHLM3 consortium. Eklund M, et al. Among authors: discacciati a. N Engl J Med. 2021 Sep 2;385(10):908-920. doi: 10.1056/NEJMoa2100852. Epub 2021 Jul 9. N Engl J Med. 2021. PMID: 34237810 Clinical Trial.
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality.
Björnebo L, Nordström T, Discacciati A, Palsdottir T, Aly M, Grönberg H, Eklund M, Lantz A. Björnebo L, et al. Among authors: discacciati a. JAMA Oncol. 2022 Jul 1;8(7):1019-1026. doi: 10.1001/jamaoncol.2022.1501. JAMA Oncol. 2022. PMID: 35587340
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H; STHLM3 study group. Nordström T, et al. Among authors: discacciati a. Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13. Lancet Oncol. 2021. PMID: 34391509 Clinical Trial.
Modeling the probability of occurrence of events.
Bottai M, Discacciati A, Santoni G. Bottai M, et al. Among authors: discacciati a. Stat Methods Med Res. 2021 Aug;30(8):1976-1987. doi: 10.1177/09622802211022403. Epub 2021 Jul 7. Stat Methods Med Res. 2021. PMID: 34232832 Clinical Trial.
MRI-Targeted Biopsy in Prostate Cancer Screening. Reply.
Eklund M, Discacciati A, Nordström T. Eklund M, et al. Among authors: discacciati a. N Engl J Med. 2021 Nov 25;385(22):2110-2111. doi: 10.1056/NEJMc2115775. N Engl J Med. 2021. PMID: 34818498 No abstract available.
One-stage dose-response meta-analysis for aggregated data.
Crippa A, Discacciati A, Bottai M, Spiegelman D, Orsini N. Crippa A, et al. Among authors: discacciati a. Stat Methods Med Res. 2019 May;28(5):1579-1596. doi: 10.1177/0962280218773122. Epub 2018 May 9. Stat Methods Med Res. 2019. PMID: 29742975
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.
Files DC, Matthay MA, Calfee CS, Aggarwal NR, Asare AL, Beitler JR, Berger PA, Burnham EL, Cimino G, Coleman MH, Crippa A, Discacciati A, Gandotra S, Gibbs KW, Henderson PT, Ittner CAG, Jauregui A, Khan KT, Koff JL, Lang J, LaRose M, Levitt J, Lu R, McKeehan JD, Meyer NJ, Russell DW, Thomas KW, Eklund M, Esserman LJ, Liu KD; ISPY COVID Adaptive Platform Trial Network; undefined. Files DC, et al. Among authors: discacciati a. BMJ Open. 2022 Jun 6;12(6):e060664. doi: 10.1136/bmjopen-2021-060664. BMJ Open. 2022. PMID: 35667714 Free PMC article. Clinical Trial.
67 results